Search Prime Grants

R44DK131644

Project Grant

Overview

Grant Description
Validation of a Bedside Automated 3D Ultrasound-Based Arteriovenous Fistula Cannulation Guidance Solution to Improve AV Fistula Outcomes - Project Summary/Abstract

End-stage renal disease (ESRD) affects 4.3 million patients worldwide and accounts for 7% of all Medicare and Medicaid costs. Hemodialysis, the most prevalent modality of renal replacement, requires access to the circulation through which dialysis machinery is connected. The preferred method of access is an arteriovenous (AV) fistula as it confers lower rates of mortality, infection, and interventions. However, AV fistulas are the most challenging for dialysis technicians to cannulate. Cannulation damage is one of the primary causes of AV fistula complications and failure, with cannulation failures and injury occurring in 91% of patients within 6 months. These injuries can lead to serious complications, such as hematoma, infection, and aneurysm formation, including death from hemorrhage, with a secondary impact on morbidity, hospitalization, access revision, and loss of access.

The annual rate of major infiltration is 5.2%, with each incident leading to an extra 97 days of catheter dependency and a mean of 2.4 diagnostic tests, surgery appointments, or interventions. When factoring in the additional catheter time and secondary interventions, the financial impact is $21,441 per major infiltration. Ultrasound has been demonstrated to dramatically improve outcomes by reducing central venous catheter (CVC) time by over 30% (50 days) and infections by 37%. However, this was in the hands of nephrology physicians in a study setting, and current ultrasound options are too challenging for dialysis technicians and are therefore not used.

We have developed an automated 3D ultrasound-based navigation solution, Echoguide, that is purpose-built for dialysis technicians to improve cannulation without specialized training. This study proposes to prove that Echoguide, when used by dialysis technicians, can substantially reduce cannulation errors and infiltrations for AV fistulae. In this Phase II proposal, we will (1) develop the integrated Echoguide with custom probe/display hardware, lumen detection algorithms, and real-time interactive navigation; (2) iterate the user interface via human factors development to optimize navigation guidance; and (3) extend a validated AVF cannulation simulator to enable ultrasound compatibility in order to demonstrate Echoguide's effectiveness in improving cannulation success by technicians across challenging AVF scenarios.

Overall Impact: Echoguide will allow rapid and successful cannulation of AV fistulae. This will reduce both the morbidity and costs associated with major infiltration and the associated catheter time and additional interventions.
Awardee
Funding Goals
NOT APPLICABLE
Place of Performance
Baltimore, Maryland 212244994 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the End Date has been extended from 03/14/23 to 07/31/27 and the total obligations have increased 271% from $1,000,000 to $3,709,998.
Sonavex was awarded Automated 3D Ultrasound for AV Fistula Cannulation Project Grant R44DK131644 worth $3,709,998 from the National Institute of Diabetes and Digestive and Kidney Diseases in September 2021 with work to be completed primarily in Baltimore Maryland United States. The grant has a duration of 5 years 10 months and was awarded through assistance program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research. The Project Grant was awarded through grant opportunity PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required).

SBIR Details

Research Type
SBIR Phase II
Title
Validation of a Bedside Automated 3D Ultrasound-based Arteriovenous Fistula Cannulation Guidance Solution to Improve AV Fistula Outcomes
Abstract
PROJECT SUMMARY/ABSTRACT End Stage Renal Disease (ESRD) impacts 4.3M patients worldwide and accounts for 7% of all Medicare and Medicaid costs. The most prevalent modality of renal replacement, hemodialysis, requires access to the circulation through which dialysis machinery is connected. The preferred method of access is an arteriovenous (AV) fistula as it confers lower rates of mortality, infection and interventions, however they are the most challenging for dialysis technicians to cannulate. Cannulation damage is one of the primary causes of AV fistula complications and failure. Cannulation failures and injury occur in 91% of patients within 6 months. These injuries can lead to serious complications, such as hematoma, infection, and aneurysm formation including death from hemorrhage, with a secondary impact on morbidity, hospitalization, access revision, and loss of access. The annual rate of major infiltration is 5.2%, with each incident leading to an extra 97 days of catheter dependency and a mean of 2.4 diagnostic tests, surgery appointments, or interventions. When factoring in the additional catheter time and secondary interventions, the financial impact is $21,441 per major infiltration. Ultrasound has been demonstrated to dramatically improve outcomes by reducing CVC time by andgt;30% (50 days) and infections by 37%. However, this was in the hands of nephrology physicians in a study setting and current ultrasound options are too challenging for dialysis technicians and are therefore not used. We have developed an automated 3D ultrasound-based navigation solution, EchoGuide, that is purpose build for dialysis technicians to improve cannulation without specialized training. This study proposes to prove that EchoGuide, when used by dialysis technicians, can substantially reduce cannulation errors and infiltrations for AV fistulae. In this Phase II proposal, we will (1) develop the integrated EchoGuide with custom probe/display hardware, lumen detection algorithms, and real-time interactive navigation; (2) iterate user interface via human factors development to optimize navigation guidance; and (3) extend a validated AVF cannulation simulator to enable ultrasound compatibility in order to demonstrate EchoGuide effectiveness in improving cannulation success by technicians across challenging AVF scenarios. OVERALL IMPACT: EchoGuide will allow rapid and successful cannulation of AV fistulae. This will reduce both the morbidity and costs associated with major infiltration and the associated catheter time and additional interventions.PROJECT NARRATIVE There are 4.3M patients on dialysis worldwide with End Stage Renal Disease that require access to their circulation (cannulation) to enable blood filtration via hemodialysis 3 times per week to survive. The preferred method of access, an arteriovenous (AV) fistula, is notoriously challenging for dialysis technicians to cannulate, and cannulation errors lead to serious complications such as hematoma, infection, and aneurysm formation including death from hemorrhage. We seek to commercialize a system that will allow dialysis technicians to easily cannulate AV fistulae without prior training and avoid the morbid and costly complications associated with current cannulation challenges.
Topic Code
400
Solicitation Number
PA20-260

Status
(Ongoing)

Last Modified 8/5/26

Period of Performance
9/15/21
Start Date
7/31/27
End Date
86.0% Complete

Funding Split
$3.7M
Federal Obligation
$0.0
Non-Federal Obligation
$3.7M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R44DK131644

Transaction History

Modifications to R44DK131644

Additional Detail

Award ID FAIN
R44DK131644
SAI Number
R44DK131644-2013545301
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Small Business
Awarding Office
75NK00 NIH National Institute of Diabetes and Digestive and Kidney Diseases
Funding Office
75NK00 NIH National Institute of Diabetes and Digestive and Kidney Diseases
Awardee UEI
EFQ8AGCC5HK7
Awardee CAGE
70ZR7
Performance District
MD-07
Senators
Benjamin Cardin
Chris Van Hollen

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Health and Human Services (075-0884) Health research and training Grants, subsidies, and contributions (41.0) $710,000 100%
Modified: 8/5/26